Bone Biologics Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bone Biologics Corp.
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Frequently asked questions
To buy Bone Biologics Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bone Biologics Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bone Biologics Corp. is BBLG:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bone Biologics Corp. has its primary listing on NASDAQ (Small cap). You can trade Bone Biologics Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bone Biologics Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Bone Biologics Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Bone Biologics Corp..